Latest photodynamic therapy Stories
According to the new report from BCC Research, the global photomedicine market, including drugs and devices, is expected to reach $754 million by 2019, registering a compound annual growth rate
The order in which a proposed new treatment combination is administered to mesothelioma patients appears to impact effectiveness and tumor regrowth. Raleigh,
SAN RAFAEL, Calif., Oct.
University of Mannheim Medical Center is first site opened TORONTO and CHICAGO, Oct.
Pivotal Phase 3 Clinical Trial Targeted to Begin in First Half of 2015 PRINCETON, N.J., Sept. 17, 2014 /PRNewswire/ -- Soligenix, Inc.
Ondine's President and Chief Technology Officer Dr.
Laser Approved for Treatment of PCV, CSR CLERMONT-FERRAND, France, Sept.
Newly Acquired SGX301 Orphan Drug Candidate Being Evaluated for Treatment of Cutaneous T-Cell Lymphoma PRINCETON, N.J., Sept. 5, 2014 /PRNewswire/ -- Soligenix, Inc.
TORONTO AND CHICAGO, Sept. 2, 2014 /PRNewswire/ - Concordia Healthcare Corp.
TORONTO, ON and CHICAGO, IL, Aug. 11, 2014 /PRNewswire/ - Concordia Healthcare Corp.
- Pertaining to the surface or end opposite to the mouth in a radiate animal.